{"id":"https://openalex.org/W3095928672","doi":"https://doi.org/10.1016/s0959-8049(20)31211-9","title":"Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors","display_name":"Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W3095928672","doi":"https://doi.org/10.1016/s0959-8049(20)31211-9","mag":"3095928672"},"language":"en","primary_location":{"id":"doi:10.1016/s0959-8049(20)31211-9","doi":"https://doi.org/10.1016/s0959-8049(20)31211-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0959-8049(20)31211-9","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://jdc.jefferson.edu/medoncfp/134","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022467575","display_name":"Kyriakos P. Papadopoulos","orcid":"https://orcid.org/0000-0002-0667-2620","observed_orcids":["https://orcid.org/0000-0002-0667-2620"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Papadopoulos","raw_affiliation_strings":["South Texas Accelerated Research Therapeutics, Oncology, San Antonio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Texas Accelerated Research Therapeutics, Oncology, San Antonio, USA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101836399","display_name":"Manish R. Sharma","orcid":"https://orcid.org/0000-0002-6711-1552","observed_orcids":["https://orcid.org/0000-0002-6711-1552"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Sharma","raw_affiliation_strings":["South Texas Accelerated Research Therapeutics, Oncology, Grand Rapids, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Texas Accelerated Research Therapeutics, Oncology, Grand Rapids, USA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126176806","display_name":"E. Hamilton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Hamilton","raw_affiliation_strings":["Sarah Cannon Research Institute/Tennessee Oncology, Oncology, Nashville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute/Tennessee Oncology, Oncology, Nashville, USA","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091030588","display_name":"Debra L. Richardson","orcid":"https://orcid.org/0000-0002-3992-8610","observed_orcids":["https://orcid.org/0000-0002-3992-8610"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Richardson","raw_affiliation_strings":["Stephenson Cancer Center- OK/Sarah Cannon Research Institute/TN, Oncology, Oklahoma, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stephenson Cancer Center- OK/Sarah Cannon Research Institute/TN, Oncology, Oklahoma, USA","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4390039380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070439273","display_name":"Babar Bashir","orcid":"https://orcid.org/0000-0002-6843-1179","observed_orcids":["https://orcid.org/0000-0002-6843-1179"]},"institutions":[{"id":"https://openalex.org/I2799360765","display_name":"Thomas Jefferson University Hospital","ror":"https://ror.org/04zhhva53","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799360765","https://openalex.org/I4210114575"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Bashir","raw_affiliation_strings":["Thomas Jefferson University Hospital, Oncology, Philadelphia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas Jefferson University Hospital, Oncology, Philadelphia, USA","institution_ids":["https://openalex.org/I2799360765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007003502","display_name":"G. Hodgson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Hodgson","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N. Ke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Ke","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013312474","display_name":"Qing Kang-Fortner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Q. Kang-Fortner","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101521498","display_name":"Li Na Zhou","orcid":"https://orcid.org/0000-0002-2998-0300","observed_orcids":["https://orcid.org/0000-0002-2998-0300","https://orcid.org/0000-0003-3874-4833"]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Zhou","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085654922","display_name":"William C. Zamboni","orcid":"https://orcid.org/0000-0002-8319-4482","observed_orcids":["https://orcid.org/0000-0002-8319-4482"]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Zamboni","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091087783","display_name":"Hina A. Jolin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Jolin","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Madigan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Madigan","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Kelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Kelly","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]},{"author_position":"last","author":{"id":null,"display_name":"D. Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273325","display_name":"Syros Pharmaceuticals (United States)","ror":"https://ror.org/05nj87k55","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Roth","raw_affiliation_strings":["Syros Pharmaceuticals, Clinical Development, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syros Pharmaceuticals, Clinical Development, Cambridge, USA","institution_ids":["https://openalex.org/I4405273325"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.2812,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.61439905,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"138","issue":null,"first_page":"S50","last_page":"S50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk7-inhibitor","display_name":"CDK7 inhibitor","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.6970000267028809},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.734000027179718},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7110000252723694},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7670000195503235},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":1.0},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.8270000219345093},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cdk4-6-inhibitor-resistance","display_name":"CDK4/6 inhibitor resistance","score":0.9179999828338623},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8500000238418579},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.6859999895095825},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":1.0}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7642207145690918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6827747225761414},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.6551324129104614},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6479043960571289},{"id":"https://openalex.org/C94734110","wikidata":"https://www.wikidata.org/wiki/Q18021240","display_name":"Cyclin-dependent kinase 7","level":5,"score":0.6382076740264893},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5553045272827148},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5195422768592834},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4949881434440613},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4901021420955658},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45714902877807617},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4461379051208496},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.43916356563568115},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41888123750686646},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3734189569950104},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.2812681496143341},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2547397017478943},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.17829808592796326},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15854957699775696},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.07926523685455322},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/s0959-8049(20)31211-9","doi":"https://doi.org/10.1016/s0959-8049(20)31211-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0959-8049(20)31211-9","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:jdc.jefferson.edu:medoncfp-1134","doi":null,"is_oa":true,"landing_page_url":"https://jdc.jefferson.edu/medoncfp/134","pdf_url":null,"source":{"id":"https://openalex.org/S4210178181","display_name":"The Medicine Forum","issn_l":"2325-2863","issn":["2325-2863"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Department of Medical Oncology Faculty Papers","raw_type":"abstract"},{"id":"pmh:oai:jdc.jefferson.edu:medoncposters-1012","doi":null,"is_oa":true,"landing_page_url":"https://jdc.jefferson.edu/medoncposters/12","pdf_url":null,"source":{"id":"https://openalex.org/S4210178181","display_name":"The Medicine Forum","issn_l":"2325-2863","issn":["2325-2863"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Department of Medical Oncology Posters","raw_type":"poster"}],"best_oa_location":{"id":"pmh:oai:jdc.jefferson.edu:medoncfp-1134","doi":null,"is_oa":true,"landing_page_url":"https://jdc.jefferson.edu/medoncfp/134","pdf_url":null,"source":{"id":"https://openalex.org/S4210178181","display_name":"The Medicine Forum","issn_l":"2325-2863","issn":["2325-2863"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Department of Medical Oncology Faculty Papers","raw_type":"abstract"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3203793933","https://openalex.org/W2994342338","https://openalex.org/W3030487147","https://openalex.org/W3203744844","https://openalex.org/W4379282414","https://openalex.org/W4236551207","https://openalex.org/W3209012272","https://openalex.org/W4415940967","https://openalex.org/W4236570817","https://openalex.org/W2741699902"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2020-11-09T00:00:00"}